Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HNO International (HNOI) Cash & Equivalents (2022 - 2026)

HNO International filings provide 5 years of Cash & Equivalents readings, the most recent being $81494.0 for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 70.13% to $81494.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $81494.0, a 70.13% increase, with the full-year FY2025 number at $9525.0, down 52.97% from a year prior.
  • Cash & Equivalents hit $81494.0 in Q1 2026 for HNO International, up from $9525.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.2 million in Q3 2023 to a low of $9525.0 in Q4 2025.
  • Median Cash & Equivalents over the past 5 years was $70741.5 (2024), compared with a mean of $166831.8.
  • Biggest five-year swings in Cash & Equivalents: soared 360.11% in 2023 and later tumbled 93.57% in 2024.
  • HNO International's Cash & Equivalents stood at $51109.0 in 2022, then skyrocketed by 360.11% to $235159.0 in 2023, then crashed by 91.39% to $20255.0 in 2024, then plummeted by 52.97% to $9525.0 in 2025, then skyrocketed by 755.58% to $81494.0 in 2026.
  • The last three reported values for Cash & Equivalents were $81494.0 (Q1 2026), $9525.0 (Q4 2025), and $31984.0 (Q3 2025) per Business Quant data.